Literature DB >> 27027805

Induced Pluripotent Stem Cell Therapies for Degenerative Disease of the Outer Retina: Disease Modeling and Cell Replacement.

Valentina Di Foggia1, Priyanka Makwana1, Robin R Ali2, Jane C Sowden1.   

Abstract

Stem cell therapies are being explored as potential treatments for retinal disease. How to replace neurons in a degenerated retina presents a continued challenge for the regenerative medicine field that, if achieved, could restore sight. The major issues are: (i) the source and availability of donor cells for transplantation; (ii) the differentiation of stem cells into the required retinal cells; and (iii) the delivery, integration, functionality, and survival of new cells in the host neural network. This review considers the use of induced pluripotent stem cells (iPSC), currently under intense investigation, as a platform for cell transplantation therapy. Moreover, patient-specific iPSC are being developed for autologous cell transplantation and as a tool for modeling specific retinal diseases, testing gene therapies, and drug screening.

Entities:  

Mesh:

Year:  2016        PMID: 27027805      PMCID: PMC4904163          DOI: 10.1089/jop.2015.0143

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  131 in total

1.  Three-dimensional early retinal progenitor 3D tissue constructs derived from human embryonic stem cells.

Authors:  Gabriel Nistor; Magdalene J Seiler; Fengrong Yan; David Ferguson; Hans S Keirstead
Journal:  J Neurosci Methods       Date:  2010-05-04       Impact factor: 2.390

Review 2.  A tissue-engineered approach towards retinal repair: scaffolds for cell transplantation to the subretinal space.

Authors:  Sara Royce Hynes; Erin B Lavik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-19       Impact factor: 3.117

3.  Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment.

Authors:  Jason S Meyer; Sara E Howden; Kyle A Wallace; Amelia D Verhoeven; Lynda S Wright; Elizabeth E Capowski; Isabel Pinilla; Jessica M Martin; Shulan Tian; Ron Stewart; Bikash Pattnaik; James A Thomson; David M Gamm
Journal:  Stem Cells       Date:  2011-08       Impact factor: 6.277

4.  New medium used in the differentiation of human pluripotent stem cells to retinal cells is comparable to fetal human eye tissue.

Authors:  Xiaobing Wang; Kai Xiong; Cong Lin; Lei Lv; Jing Chen; Chongchong Xu; Songtao Wang; Dandan Gu; Hua Zheng; Hurong Yu; Yan Li; Honglei Xiao; Guomin Zhou
Journal:  Biomaterials       Date:  2015-03-09       Impact factor: 12.479

5.  Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa.

Authors:  Yao Li; Yi-Ting Tsai; Chun-Wei Hsu; Deniz Erol; Jin Yang; Wen-Hsuan Wu; Richard J Davis; Dieter Egli; Stephen H Tsang
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

6.  Reengineering of aged Bruch's membrane to enhance retinal pigment epithelium repopulation.

Authors:  Tongalp H Tezel; Lucian V Del Priore; Henry J Kaplan
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-09       Impact factor: 4.799

7.  Transplanted retinal pigment epithelium modifies the retinal degeneration in the RCS rat.

Authors:  R Lopez; P Gouras; H Kjeldbye; B Sullivan; V Reppucci; M Brittis; F Wapner; E Goluboff
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-03       Impact factor: 4.799

8.  Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells.

Authors:  David E Buchholz; Sherry T Hikita; Teisha J Rowland; Amy M Friedrich; Cassidy R Hinman; Lincoln V Johnson; Dennis O Clegg
Journal:  Stem Cells       Date:  2009-10       Impact factor: 6.277

9.  Restoration of vision after transplantation of photoreceptors.

Authors:  R A Pearson; A C Barber; M Rizzi; C Hippert; T Xue; E L West; Y Duran; A J Smith; J Z Chuang; S A Azam; U F O Luhmann; A Benucci; C H Sung; J W Bainbridge; M Carandini; K-W Yau; J C Sowden; R R Ali
Journal:  Nature       Date:  2012-05-03       Impact factor: 49.962

10.  Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures.

Authors:  Bin-Kuan Chou; Prashant Mali; Xiaosong Huang; Zhaohui Ye; Sarah N Dowey; Linda Ms Resar; Chunlin Zou; Y Alex Zhang; Jay Tong; Linzhao Cheng
Journal:  Cell Res       Date:  2011-01-18       Impact factor: 25.617

View more
  6 in total

Review 1.  Biomanufacturing for clinically advanced cell therapies.

Authors:  Ayesha Aijaz; Matthew Li; David Smith; Danika Khong; Courtney LeBlon; Owen S Fenton; Ronke M Olabisi; Steven Libutti; Jay Tischfield; Marcela V Maus; Robert Deans; Rita N Barcia; Daniel G Anderson; Jerome Ritz; Robert Preti; Biju Parekkadan
Journal:  Nat Biomed Eng       Date:  2018-06-11       Impact factor: 25.671

Review 2.  Regulation of Stem Cell Properties of Müller Glia by JAK/STAT and MAPK Signaling in the Mammalian Retina.

Authors:  Krista M Beach; Jianbo Wang; Deborah C Otteson
Journal:  Stem Cells Int       Date:  2017-01-17       Impact factor: 5.443

3.  Adipose-Derived Cells (Stromal Vascular Fraction) Transplanted for Orthopedical or Neurological Purposes: Are They Safe Enough?

Authors:  Katarzyna Siennicka; Aleksandra Zolocinska; Karolina Stepien; Natalia Lubina-Dabrowska; Marzena Maciagowska; Ewa Zolocinska; Anna Slysz; Renata Piusinska-Macoch; Slawomir Mazur; Urszula Zdanowicz; Robert Smigielski; Adam Stepien; Zygmunt Pojda
Journal:  Stem Cells Int       Date:  2016-09-06       Impact factor: 5.443

4.  Cell therapy could be a potential way to improve lipoprotein lipase deficiency.

Authors:  Wenjing Wu; Yajun Yin; Jie Zhong; Yongjia Peng; Shuncai Li; Libin Zheng; Hong Cao; Jin Zhang
Journal:  Lipids Health Dis       Date:  2017-10-02       Impact factor: 3.876

5.  Use of bioreactors for culturing human retinal organoids improves photoreceptor yields.

Authors:  Patrick Ovando-Roche; Emma L West; Matthew J Branch; Robert D Sampson; Milan Fernando; Peter Munro; Anastasios Georgiadis; Matteo Rizzi; Magdalena Kloc; Arifa Naeem; Joana Ribeiro; Alexander J Smith; Anai Gonzalez-Cordero; Robin R Ali
Journal:  Stem Cell Res Ther       Date:  2018-06-13       Impact factor: 6.832

6.  Peripheral blood-derived monocytes show neuronal properties and integration in immune-deficient rd1 mouse model upon phenotypic differentiation and induction with retinal growth factors.

Authors:  Alaknanda Mishra; K Varsha Mohan; Perumal Nagarajan; Srikanth Iyer; Ashwani Kesarwani; Madhu Nath; Laxmi Moksha; Jashdeep Bhattacharjee; Barun Das; Kshama Jain; Parul Sahu; Prakriti Sinha; T Velapandian; Pramod Upadhyay
Journal:  Stem Cell Res Ther       Date:  2020-09-23       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.